EIC Cell and Gene Therapy Strategic Plan Published

The EIC Pathfinder Portfolio Strategic Plans have been published. The detailed Plans describe the activities being undertaken by each of the five EIC Portfolios to link early research with emerging or existing market opportunities in order to foster the translation of research results to innovation and commercialisation.

The Cell and Gene Therapy Portfolio Strategic Plan has been created based on collaborations agreed between individual portfolio projects. It includes activities that contribute to understand better/improve the current regulatory framework, market analysis mappings, discussions on IP management and training activities which would be beneficial to all the projects of the portfolio.